Nov 28 (Reuters) - The U.S. Food and Drug Administration (FDA) said on Tuesday it was investigating the safety risk of CAR-T therapies made by companies such as Gilead and Johnson & Johnson, after receiving reports of adverse events in patients. (Reporting by Pratik Jain in Bengaluru; Editing by Krishna Chandra Eluri)